FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Nexus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Nexus Pharmaceuticals, LLC to market a generic cyclophosphamide product under Original Application ANDA216783.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Breast Cancer
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Ovarian Cancer

Drugs mentioned

• Cyclophosphamide (generic) (cyclophosphamide)

Snippet

ORIG AP for CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE)